Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioids for breathlessness in chronic heart failure
2006-006718-13Phase 2Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic heart failure (CHF) comparing Oral morphine (Oramorph), Oral oxycodone (Oxynorm) and Placebo (3 arms). Primary endpoint: Severity of breathlessness (Borg score and NRS). Started Aug 2007; status: completed.
02
Drugs
morphineoxycodone
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2006-006718-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006718-13.